Ftse Mib
34.600,00
-0,65%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.531,96
-2,68%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Invitae Corporation (NVTA) Invitae Corporation (NVTA) Notizie

NVTA

Invitae (NVTA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:NVTA
DataOraFonteTitoloSimboloCompagnia
06/03/202414:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:NVTAInvitae Corporation
30/01/202413:00PR Newswire (US)Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsNYSE:NVTAInvitae Corporation
29/01/202422:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:NVTAInvitae Corporation
24/01/202422:34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:NVTAInvitae Corporation
22/01/202413:00PR Newswire (US)Invitae Completes Sale of Reproductive Health Assets to NateraNYSE:NVTAInvitae Corporation
22/12/202303:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
13/12/202322:07PR Newswire (US)Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsNYSE:NVTAInvitae Corporation
15/11/202301:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVTAInvitae Corporation
08/11/202322:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NVTAInvitae Corporation
08/11/202322:01PR Newswire (US)Invitae Reports Third Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
06/11/202322:00PR Newswire (US)Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research PartnershipsNYSE:NVTAInvitae Corporation
01/11/202311:59PR Newswire (US)Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023NYSE:NVTAInvitae Corporation
25/10/202317:00PR Newswire (US)Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive ResultsNYSE:NVTAInvitae Corporation
19/10/202322:30PR Newswire (US)Invitae Appoints Dr. David Sholehvar as Chief Operating OfficerNYSE:NVTAInvitae Corporation
12/10/202322:15PR Newswire (US)Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast CancerNYSE:NVTAInvitae Corporation
10/10/202322:30PR Newswire (US)Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical GenomicsNYSE:NVTAInvitae Corporation
03/10/202318:07PR Newswire (US)Invitae's Common Hereditary Cancers Panel Receives FDA Market AuthorizationNYSE:NVTAInvitae Corporation
30/09/202302:00Dow Jones NewsFDA Gives Marketing Authorization to Invitae Test for Cancer GenesNYSE:NVTAInvitae Corporation
25/09/202322:30PR Newswire (US)Invitae Announces Appointment of Finance Veteran Ana Schrank as CFONYSE:NVTAInvitae Corporation
22/09/202322:30PR Newswire (US)Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing StandardNYSE:NVTAInvitae Corporation
28/08/202322:02PR Newswire (US)Invitae Hires Industry Veteran Robert Guigley as Chief Commercial OfficerNYSE:NVTAInvitae Corporation
15/08/202313:30PR Newswire (US)Clinical Trial Results Support Genetic Testing of All Patients with Prostate CancerNYSE:NVTAInvitae Corporation
14/08/202322:02PR Newswire (US)Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFONYSE:NVTAInvitae Corporation
10/08/202322:03Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:NVTAInvitae Corporation
10/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:NVTAInvitae Corporation
09/08/202315:22Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:NVTAInvitae Corporation
08/08/202322:01PR Newswire (US)Invitae Reports Second Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
26/07/202322:01PR Newswire (US)Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023NYSE:NVTAInvitae Corporation
03/07/202320:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:NVTAInvitae Corporation
15/06/202322:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:NVTA

La tua Cronologia

NASDAQ
IUSA
NASDAQ
SFFZX
Sirios Focus Fund Retail...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network